부산대학교 도서관

Izzo F; New York Genome Center, New York, NY, USA. franco.izzo@mssm.edu.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA. franco.izzo@mssm.edu.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA. franco.izzo@mssm.edu.; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. franco.izzo@mssm.edu.; Myers RM; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Tri-Institutional MD-PhD Program, Weill Cornell Medicine, Rockefeller University, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Ganesan S; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Mekerishvili L; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Physiology, Biophysics and Systems Biology Graduate Program, Weill Cornell Medicine, New York, NY, USA.; Kottapalli S; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Prieto T; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Eton EO; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Tri-Institutional MD-PhD Program, Weill Cornell Medicine, Rockefeller University, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Botella T; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Dunbar AJ; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Bowman RL; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Sotelo J; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Potenski C; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Mimitou EP; New York Genome Center, New York, NY, USA.; Immunai, New York, NY, USA.; Stahl M; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA.; El Ghaity-Beckley S; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Arandela J; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Raviram R; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Choi DC; Laboratory of Molecular Hematopoiesis, Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA.; Richard T. Silver MD Myeloproliferative Neoplasm Center, Weill Cornell Medicine, New York, NY, USA.; Regenerative Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Hoffman R; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Chaligné R; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; SAIL: Single-cell Analytics Innovation Lab, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Abdel-Wahab O; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Smibert P; New York Genome Center, New York, NY, USA.; 10x Genomics, Pleasanton, CA, USA.; Ghobrial IM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Scandura JM; Laboratory of Molecular Hematopoiesis, Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA.; Richard T. Silver MD Myeloproliferative Neoplasm Center, Weill Cornell Medicine, New York, NY, USA.; Regenerative Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Marcellino B; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Levine RL; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Landau DA; New York Genome Center, New York, NY, USA. dlandau@nygenome.org.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA. dlandau@nygenome.org.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA. dlandau@nygenome.org.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Smalley M; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Natarajan SK; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Mondal J; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Best D; Integrative Immuno-Oncology Center, Farcast Biosciences, Woburn, Massachusetts.; Goldman D; 7730 Blackcrest Pl, Tucson, Arizona.; Shanthappa B; Integrative Immuno-Oncology Center, Farcast Biosciences, Woburn, Massachusetts.; Pellowe M; Department of Applied Mathematics, University of Waterloo, Waterloo, Ontario, Canada.; Dash C; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Saha T; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Khiste S; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Ramadurai N; Integrative Immuno-Oncology Center, Farcast Biosciences, Woburn, Massachusetts.; Eton EO; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Smalley JL; Tufts Medical School, Boston, Massachusetts.; Brown A; Division of Computational Genomics, Arrayo, Boston, Massachusetts.; Thayakumar A; Integrative Immuno-Oncology Center, Farcast Biosciences, Woburn, Massachusetts.; Rahman M; Medical and Biological Laboratories International, Woburn, Massachusetts.; Arai K; JSR Life Sciences, Minato-ku, Tokyo, Japan.; Kohandel M; Department of Applied Mathematics, University of Waterloo, Waterloo, Ontario, Canada.; Sengupta S; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. goldman1@mit.edu shiladit@mit.edu.; Goldman A; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. goldman1@mit.edu shiladit@mit.edu.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE